Institute for Cancer Research

Kjetil Taskén
Instiute head

Institute for Cancer Research has since its foundation in 1954 played a central role within the field of cancer research both in Norway and internationally. The Institute has seven research departments and more than 320 employees, master students included. About 70% of the employees and projects are externally funded. Read more

Annual report 2018 (pdf):
Abstract (in Norwegian)
Download in single page format - double page (broad) format

Publication overview

Current news and events

Olweus supported by the Novo Nordisk Foundation

Johanna Olweus
Johanna Olweus

Professor Johanna Olweus and her research team of 16 have received NOK 4.5 million in grants from the Danish Novo Nordisk Foundation. The money will be used to commercialize a whole new type of cancer immunotherapy that Olweus and her team are developing.
They have found a way to program cancer patients' immune cells to fight cancer using healthy human immune cells. This method allows the immune system to attack the cancer cells specifically, without harming other cells.

Lancet article on artificial intelligence and prediction of colorectal cancer outcome with Aftenposten front page coverage

From left: De Raedt, Danielsen and Skrede. Photo:  Stein Bjørge, Aftenposten
From left: De Raedt, Danielsen and Skrede. Photo: Stein Bjørge, Aftenposten

Findings from the Institute for Cancer Genetics and Informatics, recently published in the highly prestigious journal Lancet, has got front page coverage in the major Norwegian newspaper Aftenposten. The Lancet article - entitled "Deep learning for prediction of colorectal cancer outcome: a discovery and validation study" is jointly first-authored by Ole-Jacob Skrede and Sepp De Raedt, while institute director Håvard E. Danielsen is senior author.
Danielsen is interviewed for Aftenposten Feb 13th, and the front page newspaper article is entitled "Artificial intelligence finds cancer within 3 minutes".

Unprecedented exploration generates most comprehensive map of cancer genomes charted to date

An international team has completed the most comprehensive study of whole cancer genomes to date, significantly improving our fundamental understanding of cancer and signposting new directions for its diagnosis and treatment. The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Project (PCAWG), a collaboration involving more than 1,300 scientists and clinicians from 37 countries, analyzed more than 2,600 genomes of 38 different tumour types, creating a huge resource of primary cancer genomes.

The Department of Cancer Genetics has contributed to ICGC's catalogues of whole genomes, the foundation for the analysis performed by PCAWG.

Units and subpages

View all subunitsHide all subunits